Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals EPS Diluted (Quarterly) : -1.005 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.005 |
| March 31, 2026 | -0.0398 |
| December 31, 2025 | -0.0716 |
| September 30, 2025 | -0.7978 |
| June 30, 2025 | 0.3972 |
| March 31, 2025 | -0.2117 |
| December 31, 2024 | 0.2715 |
| September 30, 2024 | 0.6872 |
| June 30, 2024 | 0.3574 |
| March 31, 2024 | 0.0022 |
| December 31, 2023 | 0.0213 |
| September 30, 2023 | -0.2925 |
| June 30, 2023 | -0.0152 |
| March 31, 2023 | 0.2856 |
| December 31, 2022 | 0.4104 |
| September 30, 2022 | 0.0318 |
| June 30, 2022 | 0.1426 |
| March 31, 2022 | 0.4172 |
| December 31, 2021 | 0.0448 |
| September 30, 2021 | 0.3968 |
| June 30, 2021 | 0.4336 |
| March 31, 2021 | 0.1051 |
| December 31, 2020 | 0.5725 |
| September 30, 2020 | 0.744 |
| June 30, 2020 | 0.6462 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4016 |
| December 31, 2019 | 0.6175 |
| September 30, 2019 | 0.5364 |
| June 30, 2019 | 0.607 |
| March 31, 2019 | 0.3397 |
| December 31, 2018 | 0.4786 |
| September 30, 2018 | 0.5164 |
| June 30, 2018 | 0.5671 |
| March 31, 2018 | 0.4899 |
| December 31, 2017 | 0.26 |
| September 30, 2017 | 0.29 |
| June 30, 2017 | 0.32 |
| March 31, 2017 | 0.19 |
| December 31, 2016 | 0.2783 |
| September 30, 2016 | 1.18 |
| June 30, 2016 | 0.18 |
| March 31, 2016 | 0.08 |
| December 31, 2015 | 0.14 |
| September 30, 2015 | 0.08 |
| June 30, 2015 | 0.04 |
| March 31, 2015 | 0.02 |
| December 31, 2014 | 0.10 |
| September 30, 2014 | 0.39 |
| June 30, 2014 | 0.08 |
| March 31, 2014 | -0.38 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 0.9839 |
| Pfizer Inc. | -0.0435 |
| Amphastar Pharmaceuticals, Inc. | 0.6862 |
| Collegium Pharmaceutical, Inc. | -0.4637 |
| Bristol Myers Squibb Co. | 1.620 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.37M |
| Revenue (Quarterly) | 219.06M |
| Total Expenses (Quarterly) | 277.43M |
| Enterprise Value | 2.335B |
| Gross Profit Margin (Quarterly) | 72.88% |
| Profit Margin (Quarterly) | -26.65% |
| Earnings Yield | -4.24% |
| Normalized Earnings Yield | -2.469 |